Abstract

Background & aims: Histopathology is an emerging treatment target in ulcerative colitis (UC) clinical trials. Our aim was to provide guidance on standardizing biopsy collection protocols, identifying optimal evaluative indices, and defining thresholds for histologic response and remission after treatment.

Tags

Pathology, Histology, Geboes Score, Gastroenterology, Inflammatory Bowel Disease, IBD, Clinical Trials, Ulcerative Colitis, Biopsy

Read More